Skip to content

SURGEPAYS, INC.: 10-Q filed 2025-08-13

What SURGEPAYS, INC. reported in its quarterly report filed 2025-08-13 (fiscal Q2 2025): 48 published measures, 135 facts as tagged in accession 0001641172-25-023493.

This filing

Form
10-Q (quarterly report)
Filed
2025-08-13
Fiscal period
fiscal Q2 2025
Accession
0001641172-25-023493 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All SURGEPAYS, INC. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-06-3015,215,409USD
At 2024-12-3123,976,005USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-06-3015,154,017USD
At 2024-12-318,714,392USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-06-30116,116USD
At 2024-12-3115,315,919USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-06-304,404,449USD
At 2024-12-3111,790,389USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-7,082,598USD91
2025-01-01 to 2025-06-30-14,717,682USD181
2025-01-01 to 2025-03-31-7,635,084USD90
2024-04-01 to 2024-06-30-12,865,765USD91
2024-01-01 to 2024-06-30-11,641,170USD182
2024-01-01 to 2024-03-311,224,595USD91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-13,082,419USD181
2024-01-01 to 2024-06-30-90,112USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-04-01 to 2025-06-3011,518,166USD91
2025-01-01 to 2025-06-3022,095,596USD181
2024-04-01 to 2024-06-3015,085,699USD91
2024-01-01 to 2024-06-3046,514,834USD182

Contract revenue excluding tax

Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.

PeriodValueUnitDays
2025-04-01 to 2025-06-3011,518,166USD91
2025-01-01 to 2025-06-3022,095,596USD181
2024-04-01 to 2024-06-3015,085,699USD91
2024-01-01 to 2024-06-3046,514,834USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-06-304,715,069USD181
2024-01-01 to 2024-06-3023,902,632USD182

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-18,590USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-06-30-75,633,109USD
At 2024-12-31-60,915,427USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-04-01 to 2025-06-3019,889,442shares91
2025-01-01 to 2025-06-3019,978,690shares181
2024-04-01 to 2024-06-3019,431,549shares91
2024-01-01 to 2024-06-3018,562,416shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-04-01 to 2025-06-3019,889,442shares91
2025-01-01 to 2025-06-3019,978,690shares181
2024-04-01 to 2024-06-3019,431,549shares91
2024-01-01 to 2024-06-3018,562,416shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.36USD/shares91
2025-01-01 to 2025-06-30-0.74USD/shares181
2024-04-01 to 2024-06-30-0.66USD/shares91
2024-01-01 to 2024-06-30-0.63USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-0.36USD/shares91
2025-01-01 to 2025-06-30-0.74USD/shares181
2024-04-01 to 2024-06-30-0.66USD/shares91
2024-01-01 to 2024-06-30-0.63USD/shares182

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2024-04-01 to 2024-06-302,547,000USD91
2024-01-01 to 2024-06-302,970,000USD182

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-06-30457,195USD
At 2024-12-31591,088USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-04-01 to 2025-06-30155,119USD91
2025-01-01 to 2025-06-30310,238USD181
2024-04-01 to 2024-06-302,981,577USD91
2024-01-01 to 2024-06-304,478,994USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-6,810,509USD91
2025-01-01 to 2025-06-30-14,390,412USD181
2024-04-01 to 2024-06-30-10,876,053USD91
2024-01-01 to 2024-06-30-9,124,192USD182

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-06-309,694,382USD
At 2024-12-3117,870,323USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-06-308,702,069USD
At 2024-12-316,059,476USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

PeriodValueUnitDays
At 2025-06-303,300,000USD
At 2024-12-313,300,000USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2025-06-301,145,756USD
At 2024-12-311,472,962USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2025-06-302,680,713USD
At 2024-12-313,000,209USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-04-01 to 2025-06-304,155,843USD91
2025-01-01 to 2025-06-308,793,401USD181
2024-04-01 to 2024-06-307,432,978USD91
2024-01-01 to 2024-06-3013,863,783USD182

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-06-302,410,817USD
At 2024-12-311,781,365USD

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2025-04-01 to 2025-06-3014,172,832USD91
2025-01-01 to 2025-06-3027,692,607USD181
2024-04-01 to 2024-06-3018,528,774USD91
2024-01-01 to 2024-06-3041,775,243USD182

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2025-04-01 to 2025-06-304,155,843USD91
2025-01-01 to 2025-06-308,793,401USD181
2024-04-01 to 2024-06-307,432,978USD91
2024-01-01 to 2024-06-3013,863,783USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-06-3019,735,596shares
At 2024-12-3120,068,929shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-06-3077,360,756USD
At 2024-12-3176,842,878USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

PeriodValueUnitDays
At 2025-06-3061,392USD
At 2025-03-317,781,439USD
At 2024-12-3115,261,613USD
At 2024-06-3046,281,880USD
At 2024-03-3156,185,499USD
At 2023-12-3128,403,464USD

Operating lease right-of-use asset

Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.

PeriodValueUnitDays
At 2025-06-30441,225USD
At 2024-12-31564,781USD
At 2024-10-01565,650USD

Operating lease liability

Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.

PeriodValueUnitDays
At 2025-06-30446,249USD
At 2024-12-31567,301USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2025-06-309,599,366USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-06-301,625,817USD
At 2024-12-311,607,227USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-06-301,168,622USD
At 2024-12-311,016,139USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2025-06-301,145,756USD
At 2024-12-311,472,962USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-7,082,807USD91
2025-01-01 to 2025-06-30-14,718,100USD181
2024-04-01 to 2024-06-30-10,338,196USD91
2024-01-01 to 2024-06-30-8,702,765USD182

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-7,082,807USD91
2025-01-01 to 2025-06-30-14,718,100USD181
2024-04-01 to 2024-06-30-12,885,196USD91
2024-01-01 to 2024-06-30-11,672,765USD182

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-14,717,682USD181

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

PeriodValueUnitDays
2025-04-01 to 2025-06-3066,365USD91
2025-01-01 to 2025-06-30152,483USD181
2024-04-01 to 2024-06-3070,383USD91
2024-01-01 to 2024-06-30140,766USD182

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2025-04-01 to 2025-06-30163,452USD91
2025-01-01 to 2025-06-30327,206USD181
2024-04-01 to 2024-06-30163,377USD91
2024-01-01 to 2024-06-30326,754USD182

Nonoperating interest expense

Interest expense presented outside operating results. It differs from total interest expense when some borrowing cost is classified as operating or capitalized.

PeriodValueUnitDays
2025-04-01 to 2025-06-30212,419USD91
2025-01-01 to 2025-06-30331,853USD181
2024-04-01 to 2024-06-30116,722USD91
2024-01-01 to 2024-06-30249,305USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-04-01 to 2025-06-30-272,298USD91
2025-01-01 to 2025-06-30-327,688USD181
2024-04-01 to 2024-06-30537,857USD91
2024-01-01 to 2024-06-30421,427USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-06-30188,244USD181
2024-01-01 to 2024-06-30259,765USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2024-01-01 to 2024-06-3017,249,994USD182

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30-319,496USD181
2024-01-01 to 2024-06-30-8,123,897USD182

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-06-30629,452USD181
2024-01-01 to 2024-06-30-683,160USD182

Inspect the source

Entity
SURGEPAYS, INC. / CIK 0001392694
Captured
2026-09-20T07:59:34.741Z
SEC response SHA-256
9c9a709044aee411bb32ba24e21bd1beb4a496e64e73a7652ccad6c2fe7873d2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001392694.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))